Sun Pharmaceutical Industries Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-09-04 | −3111.94 | +8930.12 |
| 2026-09-03 | −2345.87 | +4977.46 |
| 2026-09-02 | +6688.37 | +2812.98 |
| 2026-09-01 | −7985.88 | +4588.88 |
| 2026-08-31 | −7985.88 | +4588.88 |
Today's Institutional Flow
On 4 September 2026, foreign institutional investors (FII) recorded a net cash outflow of ₹‑3,111.94 Cr from Indian equities, while domestic institutional investors (DII) contributed a net cash inflow of ₹ 8,930.12 Cr. The divergence underscores a robust domestic appetite against a weakening foreign sentiment. Overall, net institutional cash was ₹ 5,818.18 Cr positive, driven primarily by the DII surge.
Trend vs 5‑Day Average
The day's FII outflow exceeds the five‑day average net cash outflow of ₹‑3,333.81 Cr, indicating a slightly more aggressive pull‑back than usual. Conversely, the DII inflow of ₹ 8,930.12 Cr outpaces its five‑day average of ₹ 4,430.43 Cr, reinforcing the continuation of strong domestic buying pressure.
F&O Positioning Data
FII positions in futures‑and‑options (F&O) show a sizable net long of ₹ 374,795 Cr across the market, reflecting confidence in upside moves at the derivative level. The index futures long‑to‑short ratio stands at 1.2, suggesting a modest bias toward longer positions relative to shorts.
Healthcare Sector Flow
The healthcare sector, where Sun Pharmaceutical Industries Limited operates, has experienced a recent tilt toward DII buying while FII participation remains modestly negative, mirroring the broader market pattern.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-09-04